SCHEMBL962920

SCHEMBL962920

O=C(Nc1ccccn1)c1cccc(-c2cccc(OCc3ccc(Cl)cc3Cl)n2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.57
SIRT2 Q8IXJ6 1/20 0.51
ALDH1A1 P00352 2/20 0.47
NPC1 O15118 1/20 0.45
MITF O75030 1/20 0.45
TP53 P04637 1/20 0.45
PKM P14618 1/20 0.45
HPGD P15428 1/20 0.45
XBP1 P17861 1/20 0.45
RAB9A P51151 1/20 0.45
CNR1 P21554 1/20 0.44
GCK P35557 1/20 0.44
KCNMA1 Q12791 1/20 0.43
GRM5 P41594 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
KDM4E B2RXH2 1/20 0.43
NR4A1 P22736 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL960128 0.92 CNR2 (0.56) CNR2SIRT2ALDH1A1NPC1MITF
SCHEMBL13070651 0.83 CNR2 (0.49) CNR2SIRT2ALDH1A1NPC1RAB9A
SCHEMBL958209 0.82 NR4A2 (0.63) NPC1RAB9ANR4A1NR4A2NR4A3
SCHEMBL963967 0.77 MAP4K4 (0.54) ALDH1A1MEN1KMT2A
SCHEMBL30643223 0.73 GRM5 (0.67) CNR2SIRT2ALDH1A1NPC1RAB9A
SCHEMBL28671588 0.73 GRM5 (0.67) CNR2SIRT2ALDH1A1NPC1RAB9A
SCHEMBL14152323 0.73 CNR2 (1.00) CNR2SIRT2ALDH1A1NPC1TP53
SCHEMBL963457 0.73 PTGDR (0.54) NPC1RAB9ANR4A1NR4A2NR4A3
SCHEMBL959928 0.73 SIRT2 (0.52) CNR2SIRT2GRM5ADORA3
SCHEMBL12919104 0.72 SIRT2 (0.48) CNR2SIRT2ALDH1A1NPC1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-13 US disclosed
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-13 US disclosed
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-13 US disclosed
EP-2253618-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING Takeda Pharmaceutical Company Limited (JP) 2010-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING GPR4, NR3C2, NR5A2 CNR2 36/4885SIRT2 927/4885ALDH1A1 2384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.